Efficacy and safety of combined low-dose rituximab regimen for chronic inflammatory demyelinating polyradiculoneuropathy.
Du Y, Yan Q, Li C, Zhu W, Zhao C, Hao Y, Li L, Yao D, Zhou X, Li Y, Dang Y, Zhang R, Han L, Wang Y, Hou T, Li J, Li H, Jiang P, Wang P, Chen F, Zhu T, Liu J, Liu S, Gao L, Zhao Y, Zhang W.
Du Y, et al. Among authors: chen f.
Ann Clin Transl Neurol. 2024 Dec 11. doi: 10.1002/acn3.52270. Online ahead of print.
Ann Clin Transl Neurol. 2024.
PMID: 39660535